Top news of the week from Specialty Pharmacy Times.
SPT Staff
Advertisement
Articles by SPT Staff
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Trending News Today: Alcohol-Related Disease Beats Hepatitis C as Leading Cause for Liver Transplant
Top news of the day across the health care landscape
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Looking ahead, there are a plethora of promising new treatments for a range of specialty conditions in the 2019 drug pipeline.
Top news of the day across the health care landscape.
While there were many notable approvals, we’ve rounded up a list of 10 newly-approved therapies to know from 2018.
Here are the top articles from our hepatitis coverage of the year.
Top news of the day across the health care landscape.
Drug approvals and emerging research highlighted the news in the HIV space this past year.
Newsworthy moments, groundbreaking research, and a continuation of industry trends highlight the most read articles on Specialty Pharmacy Times® of 2018.
From clinical trials evaluating treatments to studies unearthing new discoveries about the disease's mechanism, these were some of the top newsworthy moments in multiple sclerosis research in 2018.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5
